Medtronic (MDT) Short term Debt (2014 - 2026)

Medtronic (MDT) has 13 years of Short term Debt data on file, last reported at $1.8 billion in Q2 2026.

• For the quarter ending Q2 2026, Short term Debt fell 37.79% year-over-year to $1.8 billion; the trailing twelve-month figure through Apr 2026 stood at $1.8 billion (down 37.79% YoY), and the FY2026 full-year result was $1.8 billion, down 37.79% from the prior year.
• Short term Debt climbed to $1.8 billion in Q2 2026, from $191.0 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $5.9 billion in Q1 2023 to a low of $20.0 million in Q2 2023.
• A 5-year average of $2.4 billion and a median of $1.7 billion in 2024 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt jumped 95383.33% in 2022 and sank 99.47% in 2023, its largest moves.
• Tracing MDT's Short term Debt over 5 years: stood at $5.9 billion in 2022, then plunged by 77.17% to $1.3 billion in 2023, then jumped by 177.74% to $3.7 billion in 2024, then tumbled by 61.82% to $1.4 billion in 2025, then gained by 25.92% to $1.8 billion in 2026.
• Business Quant data shows MDT's Short term Debt at $1.8 billion in Q2 2026, $191.0 million in Q1 2026, and $1.4 billion in Q4 2025.